RedHill Biopharma Ltd (RDHL) - Financial and Strategic SWOT Analysis Review

  • ID: 4278717
  • SWOT Analysis
  • 53 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Adare Pharmaceuticals Inc
  • Dexcel PT Israel Ltd
  • Nutrinia Ltd
  • Therapix Biosciences Ltd
  • Unipharm Ltd
  • MORE
RedHill Biopharma Ltd (RDHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

RedHill Biopharma Ltd (RedHill) is a biopharmaceutical company that develops and commercializes therapeutics in the areas of gastroenterology (GI) and cancer. The company’s commercial product portfolio consists of Donnatal for IBS and acute enterocolitis; Esomeprazole Strontium Delayed-Release Capsules 49.3 mg for GERD and other GI conditions; and EnteraGam, a medical food intended for the dietary management. It sells these three specialty GI products in select US territories. RedHill is investigating pipeline candidates for the treatment of GI disorders and cancer that include helicobacter pylori infection, Crohn’s disease, multiple sclerosis and pancreatic cancer among others. RedHill is headquartered in Tel Aviv, Israel.

RedHill Biopharma Ltd Key Recent Developments

May 08, 2018: RedHill Biopharma Reports First Quarter 2018 Financial Results
Apr 09, 2018: RedHill Biopharma Provides Semi-Annual Business Update
Feb 22, 2018: RedHill Biopharma Provides Fourth Quarter and Full-Year 2017 Investor Update
Dec 05, 2017: RedHill Biopharma Provides 2017 Year-End Business Update
Nov 13, 2017: RedHill Biopharma Reports 2017 Third Quarter Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Adare Pharmaceuticals Inc
  • Dexcel PT Israel Ltd
  • Nutrinia Ltd
  • Therapix Biosciences Ltd
  • Unipharm Ltd
  • MORE
Section 1 - About the Company
  • RedHill Biopharma Ltd - Key Facts
  • RedHill Biopharma Ltd - Key Employees
  • RedHill Biopharma Ltd - Key Employee Biographies
  • RedHill Biopharma Ltd - Key Operational Employees
  • RedHill Biopharma Ltd - Major Products and Services
  • RedHill Biopharma Ltd - History
  • RedHill Biopharma Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • RedHill Biopharma Ltd - Business Description
  • R&D Overview
  • RedHill Biopharma Ltd - Corporate Strategy
  • RedHill Biopharma Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • RedHill Biopharma Ltd - Strengths
  • RedHill Biopharma Ltd - Weaknesses
  • RedHill Biopharma Ltd - Opportunities
  • RedHill Biopharma Ltd - Threats
  • RedHill Biopharma Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • RedHill Biopharma Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 08, 2018: RedHill Biopharma Reports First Quarter 2018 Financial Results
  • Apr 09, 2018: RedHill Biopharma Provides Semi-Annual Business Update
  • Feb 22, 2018: RedHill Biopharma Provides Fourth Quarter and Full-Year 2017 Investor Update
  • Dec 05, 2017: RedHill Biopharma Provides 2017 Year-End Business Update
  • Nov 13, 2017: RedHill Biopharma Reports 2017 Third Quarter Financial Results
  • Nov 06, 2017: RedHill Biopharma Announces EnteraGam Poster Presentation at the ISPOR 20th Annual European Congress
  • Aug 10, 2017: RedHill Biopharma Provides 2017 Semi-Annual Business Update
  • Jul 25, 2017: RedHill Biopharma Reports 2017 Second Quarter Financial Results
  • May 03, 2017: RedHill Biopharma Reports 2017 First Quarter Financial Results
  • Mar 29, 2017: RedHill Biopharma: Notice of Annual General Meeting of Shareholders
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • RedHill Biopharma Ltd, Key Facts
  • RedHill Biopharma Ltd, Key Employees
  • RedHill Biopharma Ltd, Key Employee Biographies
  • RedHill Biopharma Ltd, Key Operational Employees
  • RedHill Biopharma Ltd, Major Products and Services
  • RedHill Biopharma Ltd, History
  • RedHill Biopharma Ltd, Subsidiaries
  • RedHill Biopharma Ltd, Key Competitors
  • RedHill Biopharma Ltd, Ratios based on current share price
  • RedHill Biopharma Ltd, Annual Ratios
  • RedHill Biopharma Ltd, Annual Ratios (Cont...1)
  • RedHill Biopharma Ltd, Interim Ratios
  • RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • RedHill Biopharma Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • RedHill Biopharma Ltd, Performance Chart (2013 - 2017)
  • RedHill Biopharma Ltd, Ratio Charts
  • RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Unipharm Ltd
  • Therapix Biosciences Ltd
  • Nutrinia Ltd
  • Dexcel PT Israel Ltd
  • Adare Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll